Diagnostic radiology & CT course

Course dates

February 2026 Dates TBC

Venue

The Royal Marsden Education and Conference Centre, Stewart’s Grove, London SW3 6JJ

Course overview

The course is organised by the Joint Department of Physics of The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research.

This course is designed to provide in-depth academic teaching of the scientific principles underpinning x-ray and CT imaging, including descriptions of the imaging components, system testing and performance, patient dosimetry, factors affecting image quality and examples of optimisation in healthcare settings.

The course is run over three days (Wednesday to Friday). Each day is designed to cover a particular theme. The first day covers the diagnostic radiology physics toolkit and the design of imaging systems; the second day focuses on performance and testing; the third day is dedicated to clinical applications, novel techniques and optimisation.

The course is primarily aimed at individuals who are undertaking formal training in medical physics. As well as being suitable for new entrants to the medical physics profession, it would also be of benefit to post-graduate students, post-doctoral research workers, physicist-managers, representatives of allied commercial organisations and anyone wishing to deepen or re-establish their understanding of the physics of medical imaging.

This is a CPD course approved by IPEM.

Provisional lecture list

  • Design of the digital x-ray unit
  • Design of the digital mammography unit
  • The multi-slice CT scanner
  • Patient dosimetry techniques
  • Reconstruction in CT
  • Digital image processing and presentation
  • PACS, DICOM and displays
  • Image quality assessment
  • Performance of digital X-ray detectors
  • X-ray quality control
  • Quantitative image quality analysis
  • Performance of CT imaging systems
  • CT quality control
  • Calculation of Effective Dose
  • Digital system design and optimisation in clinical practice
  • Developments in digital detector technology
  • Advances in x-ray imaging techniques
  • Advances in CT in radiology
  • CT in radiotherapy
  • CT in nuclear medicine
  • CT optimisation in clinical practice

Registration & Course fees

All current course registration fees are given on our registration form.

The cost includes lunches and light refreshments. Electronic copies of the presentations and a certificate of attendance are provided.

You will be allocated a place on receipt of a completed registration form and a valid quoted payment reference/purchase order or completed bank transfer/online payment. We are unable to accept provisional bookings.

The number of participants is limited, so early booking is advised.  Applications from outside the UK are welcome.

Closing date for registrations – Friday 24 January 2025.

Related documents

Provisional Timetable

Provisional Lecture Synopses

Contacts

Course Organiser: Dr Jamie Dormand

For registration details and any other queries contact:

Course Administrator: Mrs Jessica Keegan
IPEM_Approved_Logo_Black

Latest ICR News

Silencing gene may combat formation of radiation-induced scar tissue, a new study reveals

04/06/25

A new study suggests that silencing CXCL12, a gene involved in tissue scarring and repair, could help reduce the formation of scar tissue that can caused by radiotherapy. Ultimately, the researchers hope this approach could improve treatment outcomes for breast cancer patients undergoing radiotherapy and reconstructive surgery.
See full story
ASCO 2025: One-time cell therapy offers long-term survival hope for patients with advanced melanoma

02/06/25

A one-time immunotherapy treatment using a patient’s own immune cells has shown long-lasting benefit for people with advanced melanoma, a serious form of skin cancer, according to new five-year follow-up data from a pivotal clinical trial.
See full story
ASCO 2025: Next-generation breast cancer drug targets tumours before they have a chance to grow

01/06/25

A powerful new drug for advanced breast cancer can be used to treat emerging tumours, months before they have a chance to grow, helping to keep patients well for longer and delaying the need for later-line therapies including chemotherapy. Results of a global study, funded by AstraZeneca and co-led by researchers at The Institute of Cancer Research, London, The Royal Marsden NHS Foundation Trust and Institut Curie, Paris, were presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on 1 June 2025.
See full story
Professor Nick Turner (right) in his lab at the Institute of Cancer Research, London
ASCO 2025: New therapy improves survival in advanced breast cancer and delays need for chemotherapy

31/05/25

A promising new therapy can help patients with aggressive advanced breast cancer live longer and delays the need for further chemotherapy, new research has shown. Final results of the INAVO120 study, led by an international team of researchers including scientists at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, have demonstrated the potential of the new therapy combination for targeting PIK3CA-mutated hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer – a common form of the disease.
See full story